The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Open accessAbstract
Nrf2 (NF-E2-related factor-2) transcription factor regulates oxidative/xenobiotic stress response and also represses inflammation. However, the mechanisms how Nrf2 alleviates inflammation are still unclear. Here, we demonstrate that Nrf2 interferes with lipopolysaccharide-induced transcriptional upregulation of proinflammatory cytokines, including IL-6 and IL-1β. Chromatin immunoprecipitation (ChIP)-seq and ChIP-qPCR analyses revealed that Nrf2 binds to the proximity of these genes in macrophages and inhibits RNA Pol II recruitment. Further, we found that Nrf2-mediated inhibition is independent of the Nrf2-binding motif and reactive oxygen species level. Murine inflammatory models further demonstrated that Nrf2 interferes with IL6 induction and inflammatory phenotypes in vivo . Thus, contrary to the widely accepted view that Nrf2 suppresses inflammation through redox control, we demonstrate here that Nrf2 opposes transcriptional upregulation of proinflammatory cytokine genes. This study identifies Nrf2 as the upstream regulator of cytokine production and establishes a molecular basis for an Nrf2-mediated anti-inflammation approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting that Nrf2’s role in inflammation is not limited to just oxidative stress control [198].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [198]
In the citing paper
“Nrf2 has also been found to block the transcriptional upregulation of pro-inflammatory cytokine genes including interleukin 6 (IL-6) and interleukin 1 beta (IL-1β) in an ARE-independent manner through direct binding to the proximity of pro-inflammatory genes to inhibit RNA polymerase II recruitment”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [198]
In the citing paper
“the expression of pro-inflammatory cytokine genes in M1 macrophages is inhibited by Nrf2-ARE binding [198]”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [198]
In the citing paper
“it also appears to play a major role in embryo implantation in the womb, a process thought to require immunosuppression70–72.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · cited 1×
“The binding of Pol II was upregulated in LPS-treated cells at the TSS of IL6 (2), the gene body of IL6 (3) and the TSS of the IL1b gene (5), similar to the TSS of the Nqo1 gene in LPSþDEM-treated cells used as a positive control (Nqo1 TSS).”
BackgroundItoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationTargeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Self-citationData, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M. I., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,103
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)
Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., & Tada, K. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260208 · Cited by 2,258
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098 · cited 1×
“( ) : Genes within 50 kb 34 (21) 561 (203) N um be r of”
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000 · cited 1×
“The intron of the Txs gene and the promoter regions of IL6 (1) and IL1b (4) were used as negative controls.”
MethodThe UCSC Genome Browser database: update 2011
Fujita, P. A., Rhead, B., Zweig, A. S., Hinrichs, A. S., Karolchik, D., Cline, M., Goldman, M. J., Barber, G. P., Clawson, H., Coelho, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq963 · Cited by 1,843
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,812
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Gold, R., Kappos, L., Arnold, D. L., Bar‐Or, A., Giovannoni, G., Selmaj, K. W., Tornatore, C., Sweetser, M. T., Yang, M., Sheikh, S. I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114287 · Cited by 1,765
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395
Self-citationChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data
Zhu, L. J., Gazin, C., Lawson, N. D., Pagès, H., Lin, S. M., Lapointe, D. S., & Green, M. R. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-237 · Cited by 1,159
Sutton, C. E., Brereton, C. F., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,038
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
Thimmulappa, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25790 · Cited by 1,028 · cited 1×
“The binding of p65 was upregulated in LPS-treated cells at the p65-binding sites proximal to IL6 (8) and IL1b (9, 10), similarly to the 60 kb upstream site of the IL6 gene (6) used as a positive control.”
MethodTargeting inflammation in the treatment of type 2 diabetes: time to start
Donath, M. Y. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4275 · Cited by 690 · cited 1×
“The binding of Pol II was upregulated in LPS-treated cells at the TSS of IL6 (2), the gene body of IL6 (3) and the TSS of the IL1b gene (5), similar to the TSS of the Nqo1 gene in LPSþDEM-treated cells used as a positive control (Nqo1 TSS).”
BackgroundToward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680
Self-citationKatoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A., & Yamamoto, M. P. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00469.x · Cited by 533
Self-citationFriling, R. S., Bensimon, A., Tichauer, Y., & Daniel, V. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6258 · Cited by 475
Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks
Hirotsu, Y., Katsuoka, F., Funayama, R., Nagashima, T., Nishida, Y., Nakayama, K., Engel, J. D., & Yamamoto, M. P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks827 · Cited by 431
Self-citationRole of Nrf2 in the Regulation of CD36 and Stress Protein Expression in Murine Macrophages
Ishii, T., Itoh, K., Ruiz, E., Leake, D. S., Unoki‐Kubota, H., Yamamoto, M. P., & Mann, G. E. (2004) · Circulation Research · doi:10.1161/01.res.0000119171.44657.45 · Cited by 409
Self-citationItoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.36-45.2004 · Cited by 407
Self-citationOkawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T. W., & Yamamoto, M. P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.185 · Cited by 387
Self-citationPost-transcriptional regulation of gene expression in innate immunity
Carpenter, S. B., Ricci, E. P., Mercier, B. C., Moore, M. J., & Fitzgerald, K. A. (2014) · Nature reviews. Immunology · doi:10.1038/nri3682 · Cited by 374
Yoh, K., Itoh, K., Enomoto, A., Hirayama, A., Yamaguchi, N., Kobayashi, M., Morito, N., Kôyama, A., Yamamoto, M. P., & Takahashi, S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00939.x · Cited by 345
Self-citationRoe, J., Mercan, F., Rivera, K. D., Pappin, D., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.011 · Cited by 343
Harvey, C. J., Thimmulappa, R. K., Sethi, S., Kong, X., Yarmus, L. B., Brown, R. H., Feller-Kopman, D. J., Wise, R. A., & Biswal, S. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002042 · Cited by 343
Nrf2‐deficient mice are highly susceptible to cigarette smoke‐induced emphysema
Iizuka, T., Ishii, Y., Itoh, K., Kiwamoto, T., Kimura, T., Matsuno, Y., Morishima, Y., Hegab, A. E., Homma, S., Nomura, A., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00905.x · Cited by 341 · cited 1×
“The Txs intron, the Nrf2-binding site near Nqo1 gene (Nqo1 ARE) and the regions without p65 binding near the IL6 (7) and IL1b (11) genes were used as negative controls.”
MethodSelf-citationThe Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus
Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T. W., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00225-13 · Cited by 339
Self-citationUhlenhaut, N. H., Barish, G. D., Yu, R. T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hübner, N., & Evans, R. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.013 · Cited by 265
Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune responsePreprint
Barish, G. D., Yu, R. T., Karunasiri, M. S., Ocampo, C. B., Dixon, J. R., Benner, C. W., Dent, A. L., Tangirala, R. K., & Evans, R. M. (2010) · Genes & Development · doi:10.1101/gad.1998010 · Cited by 258
Ishii, Y., Itoh, K., Morishima, Y., Kimura, T., Kiwamoto, T., IIzuka, T., Hegab, A. E., Hosoya, T., Nomura, A., Sakamoto, T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6968 · Cited by 248 · cited 1×
“The binding of p65 was upregulated in LPS-treated cells at the p65-binding sites proximal to IL6 (8) and IL1b (9, 10), similarly to the 60 kb upstream site of the IL6 gene (6) used as a positive control.”
MethodSelf-citationMa, Q., Battelli, L. A., & Hubbs, A. F. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051113 · Cited by 246 · cited 1×
“The binding of p65 was upregulated in LPS-treated cells at the p65-binding sites proximal to IL6 (8) and IL1b (9, 10), similarly to the 60 kb upstream site of the IL6 gene (6) used as a positive control.”
MethodOkuda, Y., Sakoda, S., Bernard, C. C. A., Fujimura, H., Saeki, Y., Kishimoto, T., & Yanagihara, T. (1998) · International Immunology · doi:10.1093/intimm/10.5.703 · Cited by 244
Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
Taguchi, K., Maher, J. M., Suzuki, T., Kawatani, Y., Motohashi, H., & Yamamoto, M. P. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01591-09 · Cited by 225
Self-citationEnhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against Sepsis
Kong, X., Thimmulappa, R. K., Craciun, F. L., Harvey, C. J., Singh, A., Kombairaju, P., Reddy, S. P., Remick, D. G., & Biswal, S. S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0271oc · Cited by 223 · cited 2×
“It has been demonstrated that Nrf2 activation by treatment with small molecule inducers, CDDO (2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid) derivatives and sulforaphane alleviates the EAE clinical score, while Nrf2-deficiency leads to increased susceptibility to EAE38–40.”
BackgroundMethodJohnson, D. A., Amirahmadi, S., Ward, C., Fabry, Z., & Johnson, J. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp274 · Cited by 210
Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
Satoh, H., Moriguchi, T., Taguchi, K., Takai, J., Maher, J. M., Suzuki, T., Winnard, P. T., Raman, V., Ebina, M., Nukiwa, T., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq105 · Cited by 197
Self-citationKong, X., Thimmulappa, R. K., Kombairaju, P., & Biswal, S. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902315 · Cited by 195
Wruck, C. J., Streetz, K. L., Pavic, G., Götz, M. E., Tohidnezhad, M., Brandenburg, L., Varoga, D. J., Eickelberg, O., Herdegen, T., Trautwein, C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162008 · Cited by 144
Li, B., Cui, W., Liu, J., Li, R., Liu, Q., Xie, X.-H., Ge, X., Zhang, J., Song, X., Wang, Y., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.002 · Cited by 138
Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels
Suzuki, T., Shibata, T., Takaya, K., Shiraishi, K., Kohno, T., Kunitoh, H., Tsuta, K., Furuta, K., Goto, K., Hosoda, F., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00065-13 · Cited by 123
Self-citationPareek, T. K., Belkadi, A., Kesavapany, S., Zaremba, A., Loh, S. L., Bai, L., Cohen, M. L., Meyer, C. J., Liby, K. T., Miller, R. H., et al. (2011) · Scientific Reports · doi:10.1038/srep00201 · Cited by 107
Roles Nrf2 Plays in Myeloid Cells and Related Disorders
Kobayashi, E. H., Suzuki, T., & Yamamoto, M. P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/529219 · Cited by 99 · cited 1×
“The intron of the Txs gene and the promoter regions of IL6 (1) and IL1b (4) were used as negative controls.”
MethodSelf-citationMaruyama, A., Tsukamoto, S., Nishikawa, K., Yoshida, A., Harada, N., Motojima, K., Ishii, T., Nakane, A., Yamamoto, M. P., & Itoh, K. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.06.004 · Cited by 99
Self-citationThe Mediator Subunit MED16 Transduces NRF2-Activating Signals into Antioxidant Gene Expression
Sekine, H., Okazaki, K., Ota, N., Shima, H., Katoh, Y., Suzuki, N., Igarashi, K., Ito, M., Motohashi, H., & Yamamoto, M. P. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00785-15 · Cited by 99
Self-citationMyeloid Lineage–Specific Deletion of Antioxidant System Enhances Tumor Metastasis
Hiramoto, K., Satoh, H., Suzuki, T., Moriguchi, T., Pi, J., Shimosegawa, T., & Yamamoto, M. P. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0094 · Cited by 94
Self-citationTsukamoto, H., Nishikata, R., Senju, S., & Nishimura, Y. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0030 · Cited by 88
Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
Burness, C. B., & Deeks, E. D. (2014) · CNS Drugs · doi:10.1007/s40263-014-0155-5 · Cited by 81
MafK positively regulates NF-κB activity by enhancing CBP-mediated p65 acetylation
Hwang, Y.-J., Lee, E., Song, J., Kim, H.-R., Jun, Y.-C., & Hwang, K. (2013) · Scientific Reports · doi:10.1038/srep03242 · Cited by 74
Hayashi, M., Takai, J., Yu, L., Motohashi, H., Moriguchi, T., & Yamamoto, M. P. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00506-15 · Cited by 31
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
“It is not clear whether NRF2 can repress prooxidant genes, but it has been reported to downregulate NOX4 and, through its ability to repress the expression of genes encoding interleukin-1β (IL-1β) and IL-6, along with induction of the gene encoding peroxisome proliferator-activated receptor gamma (PPARγ), NRF2 dampens…”
BackgroundTranscriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,280
“Together with the ‘‘default Nrf2 program,’’ Nrf2 selectively activates other genes that are specific to the cell type and the nature of the inducing agent (2, 13, 82, 89, 107, 164, 182, 188).”
BackgroundThe metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
“Finally, M2d macrophages, also known as tumor-associated macrophages (TAMs), are induced by TLR ligands and A2 adenosine receptor (A2R) agonists, or by IL-6; they secrete high levels of IL-10, TGF-β, and VEGF and low IL12, TNF-α, and IL-1β, and contribute to tumor angiogenesis, growth and metastasis (25).”
BackgroundInfluentialThe KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
Self-citation
Metadata
- Authors
- Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., & Yamamoto, M.
- Affiliations
- Tohoku University (JP)
- Miyagi Prefectural Hospital Organization (JP)
- Institute of Development, Aging and Cancer, Tohoku University (JP)
- Corresponding author
- Kobayashi, Eri H.
- Yamamoto, Masayuki
- ORCID
- Venue
- Nature Communications
- Published
- 2016-05-23
- Volume
- 7
- Issue
- 1
- Pages
- 11624-11624
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4879264
- OpenAlex
- W2400239628
- Cited by
- 1,878
- References
- 58
- Citations by year
- 2026: 188 · 2025: 244 · 2024: 245 · 2023: 214 · 2022: 243 · 2021: 209 · 2020: 236 · 2019: 115 · 2018: 109 · 2017: 61 · 2016: 13
- FWCI
- 51.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- The Japanese Biochemical Society
- Funders
- Japan Agency for Medical Research and Development (CREST)
- Ministry of Education, Culture, Sports, Science and Technology (23116002, 22118002, 24249015, CREST)
- Japan Society for the Promotion of Science (15K14414, 15H04692, 16H05147, 26111002, 24249015, 25840001, CREST, 15K08257, 16K15228)
- Core Research for Evolutional Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Nrf2, macrophages, inflammation, inflammatory cytokines, interleukin-6, IL-1β, transcriptional repression, RNA polymerase II recruitment, lipopolysaccharide, anti-inflammatory mechanism, oxidative stress response
- MeSH terms
- Animals, Gene Expression Regulation, Inflammation, Macrophages, Mice, Inbred C57BL, Mice, Inbred ICR, RNA Polymerase II, Cytokines, Mice, Knockout, Oxidative Stress, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
